Skip to main content

Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
08/25/2022
Dr Jennings highlights news from the past week, including data on Paxlovid's efficacy against the Omicron variant and updated statin recommendations from the US Preventive Services Task Force.
Dr Jennings highlights news from the past week, including data on Paxlovid's efficacy against the Omicron variant and updated statin recommendations from the US Preventive Services Task Force.
Dr Jennings highlights news from...
08/25/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/09/2023
In light of new data showing over-the-counter opioids were associated with cardiac arrhythmias, Dr Jennings calls for efforts to counsel patients accordingly.
In light of new data showing over-the-counter opioids were associated with cardiac arrhythmias, Dr Jennings calls for efforts to counsel patients accordingly.
In light of new data showing...
06/09/2023
Pharmacy Learning Network
Headshot of Douglas Jennings, PharmD
Commentary
05/31/2023
In this commentary, Douglas L. Jennings, PharmD, reviews findings from a study which tested the use of oral ritlecitinib in patients with nonsegmental vitiligo.
In this commentary, Douglas L. Jennings, PharmD, reviews findings from a study which tested the use of oral ritlecitinib in patients with nonsegmental vitiligo.
In this commentary, Douglas L....
05/31/2023
First Report Managed Care
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
07/21/2021
This week, Dr Jennings reviews two new papers that were recently published regarding antiplatelet therapy in acute coronary syndrome.
This week, Dr Jennings reviews two new papers that were recently published regarding antiplatelet therapy in acute coronary syndrome.
This week, Dr Jennings reviews...
07/21/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
03/16/2022
Dr Jennings discusses COVID-19 treatment efficacy as new variants emerge, as well as the management of drug-drug interactions between these treatments and other medications.
Dr Jennings discusses COVID-19 treatment efficacy as new variants emerge, as well as the management of drug-drug interactions between these treatments and other medications.
Dr Jennings discusses COVID-19...
03/16/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
10/20/2022
Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients.
Dr Jennings shares a new study which suggests lower doses of guideline-directed medical therapy might still produce a significant benefit for patients.
Dr Jennings shares a new study...
10/20/2022
Pharmacy Learning Network
Talking Therapeutics
11/04/2023
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss the ACORN study, which compared the outcomes of cefepime vs pip-tazo in patients with hospital-acquired infections.
In this week’s issue, we discuss...
11/04/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
12/21/2022
Dr Jennings walks through findings from a new study comparing 2 dosing regimens of mycophenolate mofetil in patients who had heart transplant surgery.
Dr Jennings walks through findings from a new study comparing 2 dosing regimens of mycophenolate mofetil in patients who had heart transplant surgery.
Dr Jennings walks through...
12/21/2022
Pharmacy Learning Network
douglas jennings
Commentary
10/07/2021
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment options have burgeoned and patient management has democratized well beyond HIV specialists into fields such as primary and family care, clinicians are compelled to remain abreast of key practice updates,” says...
“As the number of HIV treatment...
10/07/2021
First Report Managed Care
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
06/02/2022
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of Talking Therapeutics, Dr Jennings shares research into whether electronic health record alerts can improve the prescription of medical therapy.
In the newest installment of...
06/02/2022
Pharmacy Learning Network